ArticleScientific reports2026
Smoke water and smoke-derived karrikinolide, KAR
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hydrogel-Based Controlled Release of Phytohormones: Improving Bioavailability and Early Plant Development Outcomes.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Seed dormancy challenges medicinal and aromatic plant (MAP) cultivation, often requiring lengthy cold stratification or application of germination stimulants such as gibberellic acid (GA₃). We evaluated if karrikinolide (KAR1), smoke water (SW) and food-grade liquid smoke treatments would break dormancy of five MAPs—Alchemilla xanthochlora (yellow-green lady’s mantle), Lavandula angustifolia (true lavender), Rhodiola rosea (golden root), Verbena officinalis (common vervain), and Veronica officinalis (heath speedwell). We hypothesised that KAR1 and SW treatments would break dormancy in species originating in Mediterranean-type ecosystems (lavender, common vervain), offering comparable efficacy to GA₃. KAR1 treatments at 1 μM and 10 μM significantly increased final germination percentage (FGP) in lavender, with cultivar ‘Rapido’ reaching 58.5% and 65.5%, and cultivar ‘Carla’ achieving 34% and 31.5%, compared to GA₃ which produced 67% and 49.5% FGP respectively. In heath speedwell, KAR1 treatments from 0.001 to 10 μM consistently had high FGP (94.5–100%), comparable to GA₃ treatment at 94.5%, indicating near-complete dormancy alleviation. However, only heath speedwell achieved germination speeds similar to GA₃ with KAR1. SW treatments were variable: while Veronica officinalis responded positively at 1:10 and 1:1000 dilutions, Lavandula angustifolia showed no response at these concentrations, and undiluted SW inhibited germination for all species. No detectable response to KAR1 was observed for yellow-green lady’s mantle and golden root. Despite not significantly increasing total germination of common vervain, KAR1 increased germination speed, while SW treatments were less pronounced. While GA₃ was consistently effective in breaking dormancy—except for common vervain—KAR1 and SW treatments are viable alternatives for lavender and heath speedwell. Optimisation of KAR1 concentrations and SW formulations may enhance efficacy. SW could offer a novel, sustainable method, potentially compatible with organic production, for improving germination and thus cultivation of these MAP species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.